The effect of blockade of dopamine receptors on the inhibition of episodic luteinizing hormone release during electrical stimulation of the arcuate nucleus in ovairiectomized rats

Endocrinology

Volumn 102, Issue 4, 1978, Pages 1026-1035

  Gallo, Robert V ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

APOMORPHINE; BUTACLAMOL; DOPAMINE; DOPAMINE RECEPTOR; PIMOZIDE;

ANIMAL EXPERIMENT; ARCUATE NUCLEUS; BRAIN DEPTH STIMULATION; CENTRAL NERVOUS SYSTEM; ENDOCRINE SYSTEM; HYPOTHALAMUS; INTRAPERITONEAL DRUG ADMINISTRATION; LUTEINIZING HORMONE RELEASE; OVARIECTOMY; RAT;

ANIMAL; BUTACLAMOL; CASTRATION; DOPAMINE; ELECTRIC STIMULATION; FEMALE; HYPOTHALAMUS; LUTEINIZING HORMONE; PIMOZIDE; RATS; RECEPTORS, DOPAMINE; SUPPORT, U.S. GOV'T, P.H.S.;

EID: 0018148106     PISSN: 00137227     EISSN: 19457170     Source Type: Journal    
DOI: 10.1210/endo-102-4-1026     Document Type: Article

References (26)

1. Gallo, R. V., and R. B. Osland, Electrical stimulation of the arcuate nucleus in ovariectomized rats inhibits episodic luteinizing hormone (LH) release but excites LH release after estrogen priming, Endocrinology 99: 659, 1976.
2. Gallo, R. V., and G. Moberg, Serotonin-mediated inhibition of episodic luteinizing hormone release during electrical stimulation of the arcuate nucleus in ovariectomized rats, Endocrinology 100: 945, 1977.
3. Johnson, G. A., E. G. Kim, and S. J. Boukma, Mechanism of norepinephrine depletion by 5-hydroxytryp-tophan, Proc Soc Exp Biol Med 128: 509, 1968.
4. Fuxe, K., L. L. Butcher, and J. Engel, DL-5-Hydrox-ytryptophan-induced changes in central monoamine neurons after peripheral decarboxylase inhibition, J Pharm Pharmacol 23: 420, 1971.
5. 3H] dopamine by L-5-hydroxytryp-tophan, Brain Res 45: 499, 1972.
6. Drouva, S. V., and R. V. Gallo, Catecholamine involvement in episodic luteinizing hormone release in adult ovariectomized rats, Endocrinology 99: 651, 1976.
7. Drouva, S. V., and R. V. Gallo, Further evidence for inhibition of episodic luteinizing hormone release in ovariectomized rats by stimulation of dopamine receptors, Endocrinology 100: 792, 1977.
8. Gnodde, H. P., and G. A. Schuiling, Involvement of catecholaminergic and cholinergic mechanisms in the pulsatile release of LH in the long term ovariectomized rat, Neuroendocrinology 20: 212, 1976.
9. Fuxe, K., Distribution of monoamine nerve terminals in the central nervous system, Acta Physiol Scand (Suppl. 64) 247: 37, 1965.
10. Bjorklund, A., R. Y. Moore, A. Nobin, and U. Stenevi, The organization of tubero-hypophyseal and reticulo-infundibular catecholamine neuron system in the rat brain, Brain Res 51: 171, 1973.
11. Bjorklund, A., and A. Nobin, Fluorescence histochem-ical and microspectrofluorometric mapping of dopamine and noradrenaline cell groups in the rat diencephalon, Brain Res 51: 193, 1973.
12. Palkovits, M., M. Brownstein, J. M. Saavedra, and J. Axelrod, Norepinephrine and dopamine content of hypothalamic nuclei of the rat, Brain Res 77: 137, 1974.
13. Voith, K., and F. Herr, The behavioral pharmacology of butaclamol hydrochloride (AY-23, 028), a new potent neuroleptic drug, Psychopharmacologia (Bert) 42: 11, 1975.
14. Lippmann, W., and T. A. Pugsley, The effects of butaclamol hydrochloride a new neuroleptic drug, on catecholamine turnover, Pharmacol Res Commun 7: 371, 1975.
15. Lippmann, W., T. Pugsley, and J. Merker, Effect of butaclamol and its enantiomers upon striatal homovanillic acid and adenyl cyclase of olfactory tubercle in rats, Life Sci 16: 213, 1975.
16. Janssen, P. A. J., C. J. E. Niemeggers, K. H. L. Schellekens, A. Dresse, F. M. Lenaerts, A. Pinchard, W. K. A. Schaper, J. M. Van Neuten, and F. J. Verbruggen, Pimozide, a chemically novel, highly potent and orally long-acting neuroleptic drug, Arzneim Forsch 18: 261, 1968.
17. Anden, N. E., A. Rubenson, K. Fuxe, and T. Hokfelt, Evidence for dopamine receptor stimulation by apo-morphine, J Pharm Pharmacol 19: 627, 1967.
18. Ernst, A. M., Mode of action of apomorphine and dexamphetamine on gnawing compulsion in rats, Psychopharmacologia 10: 316, 1967.
19. deGroot, J., The Rat Forebrain in Stereotaxic Coordinates, North Holland, Amsterdam, 1959, p. 1.
20. Osland, R. B., R. V. Gallo, and J. A. Williams, In vitro release of luteinizing hormone from anterior pituitary fragments superfused with constant or pulsatile amounts of luteinizing hormone-releasing factor, Endocrinology 96: 1210, 1975.
21. 131I, Proc Soc Exp Biol Med 128: 807, 1968.
22. Palkovits, M., A. Arimura, M. Brownstein, A. V. Schally, and J. M. Saavedra, Luteinizing hormonereleasing hormone (LHRH) content of the hypothalamic nuclei in the rat, Endocrinology 95: 554, 1974.
23. Wheaton, J. E., L. Krulich, and S. M. McCann, Localization of luteinizing hormone-releasing hormone in the preoptic area and hypothalamus of the rat using radioimmunoassay, Endocrinology 97: 30, 1975.
24. Saavedra, J. M., M. Palkovits, M. J. Brownstein, and J. Axelrod, Serotonin distribution in the nuclei of the rat hypothalamus and preoptic region, Brain Res 77: 157, 1974.
25. Pugsley, T. A., and W. Lippmann, Effect of butaclamol, a new neuroleptic, on serotoninergic mechanisms, J Pharm Pharmacol 29: 135, 1977.
26. Bennett, J. P., Jr., and S. H. Snyder, Serotonin and lysergic acid diethylamide binding in rat brain membranes: relationship to postsynaptic serotonin receptors, Mol Pharmacol 12: 373, 1976.